Sort
46,585 grants matching “heart failure”
Disease Outcomes iN Older adults under extreme Heat, AiR pollution and Medication use (DO-NO-HARM)
$529,316Soko Setoguchi-Iwata · Rutgers, The State Univ Of N.J. · R01 · FY2021 · AG
Wake Forest Atrium HeartShare Clinical Center
$529,299Dalane W Kitzman · Wake Forest University Health Sciences · U01 · FY2025 · HL
Impact of Prenatal Hypoxia on Mitochondrial Function of Offspring Hearts
$529,212Loren P Thompson · University Of Maryland Baltimore · R01 · FY2019 · HL
Impact of Prenatal Hypoxia on Mitochondrial Function of Offspring Hearts
$529,212Loren P Thompson · University Of Maryland Baltimore · R01 · FY2020 · HL
Impact of Prenatal Hypoxia on Mitochondrial Function of Offspring Hearts
$529,212Eugene D Albrecht · University Of Maryland Baltimore · R01 · FY2022 · HL
Impact of Prenatal Hypoxia on Mitochondrial Function of Offspring Hearts
$529,212Loren P Thompson · University Of Maryland Baltimore · R01 · FY2021 · HL
Lethal H5N1 Virus Infection and Respiratory Disorders
$529,200Fadi Xu · Lovelace Biomedical & Environmental Research Institute · R01 · FY2014 · HL
Cardiovascular health and exposure to PM2.5 constituents: a multi-cohort study
$529,196Yang Liu · Emory University · R01 · FY2023 · ES
Complement-Mediated Exosome Function in Transplantation
$529,171Nicholas Chun · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AI
Complement-Mediated Exosome Function in Transplantation
$529,171Nicholas Chun · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · AI
Complement-Mediated Exosome Function in Transplantation
$529,171Nicholas Chun · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AI
Actin and focal adhesion remodeling as therapeutic targets in cardiovascular disease
$529,157Kathleen G Morgan · Boston University (Charles River Campus) · R01 · FY2021 · AG
Actin and focal adhesion remodeling as therapeutic targets in cardiovascular disease
$529,157Kathleen G Morgan · Boston University (Charles River Campus) · R01 · FY2020 · AG
Actin and focal adhesion remodeling as therapeutic targets in cardiovascular disease
$529,157Kathleen G Morgan · Boston University (Charles River Campus) · R01 · FY2019 · AG
The Role of Ischemia Reperfusion Injury in Lung Allograft Rejection
$529,123Daniel Kreisel · Washington University · R01 · FY2019 · HL
PET Imaging of Myocardial Oxidative Stress in T2DM
$529,113Robert J Gropler · Washington University · R01 · FY2012 · EB
Structural and dynamic analysis of GRK interaction with G protein-coupled receptors
$529,100Jeffrey L Benovic · Thomas Jefferson University · R01 · FY2020 · HL
Cardiovascular Peptides and Myocardial Infarction
$529,087John C Burnett · Mayo Clinic Rochester · R01 · FY2014 · HL
Nitric Oxide as a Modifier of Oxidative Stress
$529,061David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2021 · CA
Establishing and reversing the functional consequences of Titin truncation mutations
$529,054John Travis Hinson · University Of Connecticut Sch Of Med/Dnt · R01 · FY2023 · HL
Establishing and reversing the functional consequences of Titin truncation mutations
$529,054John Travis Hinson · University Of Connecticut Sch Of Med/Dnt · R01 · FY2025 · HL
Actin and focal adhesion remodeling as therapeutic targets in cardiovascular disease
$529,023Kathleen G Morgan · Boston University (Charles River Campus) · R01 · FY2018 · AG
Improving Quality by Maintaining Accurate Problem Lists in the EHR (IQ-MAPLE)
$528,987Adam T Wright · Brigham And Women'S Hospital · R01 · FY2017 · HL
IGF::OT::IGF RD CORONERY ARTERY RISK DEVELOPMENT IN YOUNG ADULTS (CARDIA) UMN FI
$528,955Pamela Shreiner · University Of Minnesota · N01 · FY2017 · HL
Improving Cardiac Rehabilitation outcomes through mobile case management (iCARE)
$528,945Thomas Patrick Olson · Mayo Clinic Rochester · R01 · FY2024 · NR